Nuclear Medicine Market Forecast 2025-2031: Industry Trends, Growth Opportunities, and Strategic Insights in New Research Report | Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma

LOS ANGELES, United States: The global Nuclear Medicine market was valued at US$ 6875 million in 2024 and is anticipated to reach US$ 11090 million by 2031, witnessing a CAGR of 7.4% during the forecast period 2025-2031. A recent report published by QY Research, titled, "Global Nuclear Medicine Market Insights - Industry Share, Sales Projections, and Demand Outlook 2025-2031", provides an in-depth analysis of the global Nuclear Medicine market.

The global Nuclear Medicine market is comprehensively analyzed in the report with the main objective of providing accurate market data and useful recommendations to help players to gain strong growth in future. The report is compiled by subject matter experts and experienced market analysts, which makes it highly authentic and reliable. Readers are provided with deep analysis of historical and future market scenarios to get sound understanding of market competition and other important aspects. The report offers exhaustive research on market dynamics, key segments, leading players, and different regional markets.

Request for Exclusive Research Report PDF Sample Copy: https://www.qyresearch.in/request-sample/medical-care-global-nuclear-medicine-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Market Drivers

The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.

Market Challenges

Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.

The competitive landscape of the global Nuclear Medicine market is broadly studied in the report with large focus on recent developments, future plans of top players, and key growth strategies adopted by them. The analysts authoring the report have profiled almost every major player of the global Nuclear Medicine market and thrown light on their crucial business aspects such as production, areas of operation, and product portfolio. All companies analyzed in the report are studied on the basis of vital factors such as market share, market growth, company size, production volume, revenue, and earnings.

Key Players Mentioned in the Global Nuclear Medicine Market Research Report:

Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng

The report offers great insights into important segments of the global Nuclear Medicine market while concentrating on their CAGR, market size, market share, and future growth potential. The global Nuclear Medicine market is mainly segmented according to type of product, application, and region. Each segment in these categories is extensively researched to become familiar with their growth prospects and key trends. Segmental analysis is highly important to identify key growth pockets of a global market. The report provides specific information on the market growth and demand of different products and applications to help players to focus on profitable areas of the global Nuclear Medicine market.

Segment by Type

Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

Segment by Application

Oncology
Thyroid
Cardiology
Others

In the regional segment chapter, various regions are studied on the basis of manufacturing and consumption of the product. The research report analyzes the geographically segments present in the global Nuclear Medicine market. It then further divides the regions into countries wise to provide a magnified view all the details of the market.

Key Questions Answered

The report answers important questions that companies may have when operating in the global Nuclear Medicine market. Some of the questions are given below:

(1) What will be the size of the global Nuclear Medicine market in 2025?

(2) What is the current CAGR of the global Nuclear Medicine market?

(3) Which product is expected to show the highest market growth?

(4) Which application is projected to gain a lion's share of the global Nuclear Medicine market?

(5) Which region is foretold to create the most number of opportunities in the global Nuclear Medicine market?

(6) Will there be any changes in market competition during the forecast period?

(7) Which are the top players currently operating in the global Nuclear Medicine market?

(8) How will the market situation change in the coming years?

(9) What are the common business tactics adopted by players?

(10) What is the growth outlook of the global Nuclear Medicine market?

Answering such types of questions can be very helpful for players to clear their doubts when implementing their strategies to gain growth in the global Nuclear Medicine market. The report offers a transparent picture of the real situation of the global Nuclear Medicine market so that companies can operate more effectively. It can be customized according to the needs of readers for better understanding of the global Nuclear Medicine market.

For Any Special Requirement and Discount Request @ https://www.qyresearch.in/pre-order-inquiry/medical-care-global-nuclear-medicine-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031

Table of Contents

1 Nuclear Medicine Market Overview
1.1 Product Definition
1.2 Nuclear Medicine by Type
1.2.1 Global Nuclear Medicine Market Value by Type (2020-2031)
1.2.2 Diagnostic Nuclear Medicine
1.2.3 Therapeutic Nuclear Medicine
1.3 Nuclear Medicine by Application
1.3.1 Global Nuclear Medicine Market Value by Application 2020-2031)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Global Nuclear Medicine Revenue (2020-2031)
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered

2 Key Insights
2.1 Key Emerging Trends
2.2 Key Developments - Mergers Acquisitions, New Product Launches, Collaborations, Partnerships and Joint Ventures
2.3 Latest Technological Advancements
2.4 Insights on Regulatory Scenarios
2.5 Porters Five Forces Analysis

3 Players Competitive Analysis
3.1 Global Nuclear Medicine Revenue by Player (2020-2025)
3.2 Nuclear Medicine Company Evaluation Quadrant
3.3 Industry Rank
3.3.1 Global Key Players of Nuclear Medicine, Industry Ranking, 2023 VS 2024
3.3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3.3 Global Nuclear Medicine Market Concentration Rate
3.3.4 Global 5 and 10 Largest Nuclear Medicine Players Market Share by Revenue
3.4 Nuclear Medicine Market: Overall Company Footprint Analysis
3.4.1 Nuclear Medicine Market: Region Footprint
3.4.2 Nuclear Medicine Market: Company Product Type Footprint
3.4.3 Nuclear Medicine Market: Company Product Application Footprint
3.4.4 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition

4 Players Profiles
4.1 Cardinal Health
4.1.1 Cardinal Health Company Details
4.1.2 Cardinal Health Business Overview
4.1.3 Cardinal Health Nuclear Medicine Introduction
4.1.4 Cardinal Health Revenue in Nuclear Medicine Business (2020-2025)
4.1.5 Cardinal Health Recent Development
4.2 GE Healthcare
4.2.1 GE Healthcare Company Details
4.2.2 GE Healthcare Business Overview
4.2.3 GE Healthcare Nuclear Medicine Introduction
4.2.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
4.2.5 GE Healthcare Recent Development
4.3 Jubilant Pharma
4.3.1 Jubilant Pharma Company Details
4.3.2 Jubilant Pharma Business Overview
4.3.3 Jubilant Pharma Nuclear Medicine Introduction
4.3.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
4.3.5 Jubilant Pharma Recent Development
4.4 Novartis
4.4.1 Novartis Company Details
4.4.2 Novartis Business Overview
4.4.3 Novartis Nuclear Medicine Introduction
4.4.4 Novartis Revenue in Nuclear Medicine Business (2020-2025)
4.4.5 Novartis Recent Development
4.5 Curium Pharma
4.5.1 Curium Pharma Company Details
4.5.2 Curium Pharma Business Overview
4.5.3 Curium Pharma Nuclear Medicine Introduction
4.5.4 Curium Pharma Revenue in Nuclear Medicine Business (2020-2025)
4.5.5 Curium Pharma Recent Development
4.6 SIEMENS
4.6.1 SIEMENS Company Details
4.6.2 SIEMENS Business Overview
4.6.3 SIEMENS Nuclear Medicine Introduction
4.6.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
4.6.5 SIEMENS Recent Development
4.7 Lantheus
4.7.1 Lantheus Company Details
4.7.2 Lantheus Business Overview
4.7.3 Lantheus Nuclear Medicine Introduction
4.7.4 Lantheus Revenue in Nuclear Medicine Business (2020-2025)
4.7.5 Lantheus Recent Development
4.8 Bracco Imaging
4.8.1 Bracco Imaging Company Details
4.8.2 Bracco Imaging Business Overview
4.8.3 Bracco Imaging Nuclear Medicine Introduction
4.8.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
4.8.5 Bracco Imaging Recent Development
4.9 Bayer
4.9.1 Bayer Company Details
4.9.2 Bayer Business Overview
4.9.3 Bayer Nuclear Medicine Introduction
4.9.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
4.9.5 Bayer Recent Development
4.10 Eli Lilly
4.10.1 Eli Lilly Company Details
4.10.2 Eli Lilly Business Overview
4.10.3 Eli Lilly Nuclear Medicine Introduction
4.10.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
4.10.5 Eli Lilly Recent Development
4.11 Aurobindo Pharma
4.11.1 Aurobindo Pharma Company Details
4.11.2 Aurobindo Pharma Business Overview
4.11.3 Aurobindo Pharma Nuclear Medicine Introduction
4.11.4 Aurobindo Pharma Revenue in Nuclear Medicine Business (2020-2025)
4.11.5 Aurobindo Pharma Recent Development
4.12 Mundipharma
4.12.1 Mundipharma Company Details
4.12.2 Mundipharma Business Overview
4.12.3 Mundipharma Nuclear Medicine Introduction
4.12.4 Mundipharma Revenue in Nuclear Medicine Business (2020-2025)
4.12.5 Mundipharma Recent Development
4.13 China Isotope & Radiation
4.13.1 China Isotope & Radiation Company Details
4.13.2 China Isotope & Radiation Business Overview
4.13.3 China Isotope & Radiation Nuclear Medicine Introduction
4.13.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
4.13.5 China Isotope & Radiation Recent Development
4.14 Yantai Dongcheng
4.14.1 Yantai Dongcheng Company Details
4.14.2 Yantai Dongcheng Business Overview
4.14.3 Yantai Dongcheng Nuclear Medicine Introduction
4.14.4 Yantai Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
4.14.5 Yantai Dongcheng Recent Development

5 Analysis by Region
5.1 Global Nuclear Medicine Market Size by Region
5.1.1 Global Nuclear Medicine Revenue by Region: 2020 VS 2024 VS 2031
5.1.2 Global Nuclear Medicine Revenue by Region (2020-2025)
5.1.3 Global Nuclear Medicine Revenue by Region (2026-2031)
5.1.4 Global Nuclear Medicine Revenue Market Share by Region (2020-2031)
5.2 North America Nuclear Medicine Revenue (2020-2031)
5.3 Europe Nuclear Medicine Revenue (2020-2031)
5.4 Asia-Pacific Nuclear Medicine Revenue (2020-2031)
5.5 South America Nuclear Medicine Revenue (2020-2031)
5.6 Middle East & Africa Nuclear Medicine Revenue (2020-2031)

6 Market Scenario by Region & Country
6.1 Global Nuclear Medicine Revenue by Region & Country: 2020 Versus 2024 Versus 2031
6.2 Global Nuclear Medicine Revenue by Region & Country (2020-2031)
6.3 North America Nuclear Medicine Market Facts & Figures by Country
6.3.1 North America Nuclear Medicine Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 North America Nuclear Medicine Revenue by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe Nuclear Medicine Market Facts & Figures by Country
6.4.1 Europe Nuclear Medicine Revenue by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Nuclear Medicine Revenue by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific Nuclear Medicine Market Facts & Figures by Region
6.5.1 Asia Pacific Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Nuclear Medicine Revenue by Region (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 Taiwan
6.5.9 Indonesia
6.5.10 Thailand
6.5.11 Malaysia
6.5.12 Philippines
6.6 South America Nuclear Medicine Market Facts & Figures by Country
6.6.1 South America Nuclear Medicine Market Size by Country: 2020 VS 2024 VS 2031
6.6.2 South America Nuclear Medicine Revenue by Country
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Argentina
6.7 Middle East and Africa Nuclear Medicine Market Facts & Figures by Country
6.7.1 Middle East and Africa Nuclear Medicine Market Size by Country: 2020 VS 2024 VS 2031
6.7.2 Middle East and Africa Nuclear Medicine Revenue by Country
6.7.3 Turkey
6.7.4 Saudi Arabia
6.7.5 U.A.E

7 Segment by Type
7.1 Global Nuclear Medicine Revenue by Type (2020-2025)
7.2 Global Nuclear Medicine Revenue by Type (2026-2031)
7.3 Global Nuclear Medicine Revenue Market Share by Type (2020-2031)

8 Segment by Application
8.1 Global Nuclear Medicine Revenue by Application (2020-2025)
8.2 Global Nuclear Medicine Revenue by Application (2026-2031)
8.3 Global Nuclear Medicine Revenue Market Share by Application (2020-2031)

9 Industry Chain and Sales Channels Analysis
9.1 Nuclear Medicine Industry Chain Analysis
9.2 Nuclear Medicine Key Raw Materials
9.2.1 Key Raw Materials
9.2.2 Raw Materials Key Suppliers
9.3 Nuclear Medicine Production Mode & Process
9.4 Nuclear Medicine Sales and Marketing
9.4.1 Nuclear Medicine Sales Channels
9.4.2 Nuclear Medicine Distributors
9.5 Nuclear Medicine Customers

10 Research Findings and Conclusion

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Author Details
11.3 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US

QY Research, INC.
India Office -
315Work Avenue, Raheja Woods, Kalyani Nagar,
Pune, Maharashtra 411006, India
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

This release was published on openPR.